| Size | Price | Stock | Qty |
|---|---|---|---|
| 1mg |
|
||
| 5mg |
|
||
| Other Sizes |
| Targets |
The primary target is the COI1–JAZ co-receptor complex; JA-Ile binds COI1 and promotes the recruitment and ubiquitination of JAZ repressor proteins, leading to their degradation by the 26S proteasome and activation of downstream jasmonate-responsive genes (e.g., MYC2, PDF1.2, VSP2); JA itself is the biosynthetic precursor of JA-Ile and other bioactive jasmonates.
|
|---|---|
| ln Vitro |
Drug compounds have included stable heavy isotopes of carbon, hydrogen, and other elements, mostly as quantitative tracers while the drugs were being developed. Because deuteration may have an effect on a drug's pharmacokinetics and metabolic properties, it is a cause for concern [1].
Jasmonic acid-d5 is used analytically to quantify JA in plant tissues by isotope dilution; JA is a precursor to the bioactive hormone JA-Ile, and exogenous JA treatment induces jasmonate-responsive gene expression, inhibits root growth, and promotes defense responses; the d5 standard enables accurate quantification of JA and its metabolites in plant hormone profiling. |
| ln Vivo |
In vivo, jasmonic acid is applied to plants to induce defense responses against herbivores and pathogens and to modulate growth and development; the d5 internal standard supports quantification of JA and JA-Ile in plant tissues after wounding, herbivory, or pathogen infection, and the jasmonate dose–response relationship is established between endogenous JA/JA-Ile levels and defense gene activation.
|
| Enzyme Assay |
JA quantification is performed by LC-MS/MS with Jasmonic acid-d5 as internal standard; plant tissues are extracted with acidified organic solvent, purified by solid-phase extraction, and analyzed in MRM mode, and the d5/d0 peak-area ratio is used for isotope-dilution quantification; JA-Ile and other jasmonates are measured in parallel to profile the jasmonate pathway.
|
| Cell Assay |
Plant cell cultures or leaf explants are treated with Jasmonic acid-d5 or unlabeled JA, and jasmonate-responsive gene expression (e.g., PDF1.2, VSP2, MYC2) is quantified by RT-qPCR; JA-Ile levels are measured by LC-MS/MS, and COI1–JAZ interaction is assessed by co-immunoprecipitation or yeast two-hybrid assays to confirm pathway activation.
|
| Animal Protocol |
In vivo plant studies treat Arabidopsis, tomato, or crop species with Jasmonic acid-d5 or unlabeled JA by spraying, root drench, or wounding; defense responses (e.g., trichome density, protease inhibitor expression, herbivore resistance) are quantified, endogenous JA and JA-Ile levels are measured by LC-MS/MS using the d5 internal standard, and the relationship between jasmonate exposure and defense output is established.
|
| References |
| Molecular Formula |
C12H18O3
|
|---|---|
| Molecular Weight |
215.300332546234
|
| CAS # |
1821807-88-8
|
| Related CAS # |
(±)-Jasmonic acid;77026-92-7
|
| Appearance |
Colorless to light yellow liquid
|
| SMILES |
CC/C=C\C[C@]1([2H])[C@@H](C([2H])([2H])C(O)=O)CC([2H])([2H])C1=O
|
| HS Tariff Code |
2934.99.9001
|
| Storage |
Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month Note: This product requires protection from light (avoid light exposure) during transportation and storage. |
| Shipping Condition |
Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)
|
| Solubility (In Vitro) |
May dissolve in DMSO (in most cases), if not, try other solvents such as H2O, Ethanol, or DMF with a minute amount of products to avoid loss of samples
|
|---|---|
| Solubility (In Vivo) |
Note: Listed below are some common formulations that may be used to formulate products with low water solubility (e.g. < 1 mg/mL), you may test these formulations using a minute amount of products to avoid loss of samples.
Injection Formulations
Injection Formulation 1: DMSO : Tween 80: Saline = 10 : 5 : 85 (i.e. 100 μL DMSO stock solution → 50 μL Tween 80 → 850 μL Saline)(e.g. IP/IV/IM/SC) *Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH ₂ O to obtain a clear solution. Injection Formulation 2: DMSO : PEG300 :Tween 80 : Saline = 10 : 40 : 5 : 45 (i.e. 100 μL DMSO → 400 μLPEG300 → 50 μL Tween 80 → 450 μL Saline) Injection Formulation 3: DMSO : Corn oil = 10 : 90 (i.e. 100 μL DMSO → 900 μL Corn oil) Example: Take the Injection Formulation 3 (DMSO : Corn oil = 10 : 90) as an example, if 1 mL of 2.5 mg/mL working solution is to be prepared, you can take 100 μL 25 mg/mL DMSO stock solution and add to 900 μL corn oil, mix well to obtain a clear or suspension solution (2.5 mg/mL, ready for use in animals). View More
Injection Formulation 4: DMSO : 20% SBE-β-CD in saline = 10 : 90 [i.e. 100 μL DMSO → 900 μL (20% SBE-β-CD in saline)] Oral Formulations
Oral Formulation 1: Suspend in 0.5% CMC Na (carboxymethylcellulose sodium) Oral Formulation 2: Suspend in 0.5% Carboxymethyl cellulose Example: Take the Oral Formulation 1 (Suspend in 0.5% CMC Na) as an example, if 100 mL of 2.5 mg/mL working solution is to be prepared, you can first prepare 0.5% CMC Na solution by measuring 0.5 g CMC Na and dissolve it in 100 mL ddH2O to obtain a clear solution; then add 250 mg of the product to 100 mL 0.5% CMC Na solution, to make the suspension solution (2.5 mg/mL, ready for use in animals). View More
Oral Formulation 3: Dissolved in PEG400  (Please use freshly prepared in vivo formulations for optimal results.) |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 4.6447 mL | 23.2234 mL | 46.4468 mL | |
| 5 mM | 0.9289 mL | 4.6447 mL | 9.2894 mL | |
| 10 mM | 0.4645 mL | 2.3223 mL | 4.6447 mL |
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.
Calculation results
Working concentration: mg/mL;
Method for preparing DMSO stock solution: mg drug pre-dissolved in μL DMSO (stock solution concentration mg/mL). Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug.
Method for preparing in vivo formulation::Take μL DMSO stock solution, next add μL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O,mix and clarify.
(1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
(2) Be sure to add the solvent(s) in order.